P. Bertrand

P. Bertrand, Fatima el Bahhaj, C. Blanquart, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Chemistry for oncotheranostic gold nanoparticles.

T. Napporn, P. Bertrand, Fatima el Bahhaj, 2015, European journal of medicinal chemistry.

Development of New Triazolyl-Based Acidic Sensitive Releasing Systems

C. Len, C. Bachmann, P. Bertrand, 2012 .

Novel triazolyl derivatives for acidic release of amines

C. Bachmann, P. Bertrand, G. Frapper, 2011 .

Triazolyl Derivatives for Acidic Release of Alcohols

C. Len, C. Bachmann, P. Bertrand, 2011 .

Click chemistry with O-dimethylpropargylcarbamate for preparation of pH-sensitive functional groups. A case study.

P. Bertrand, J. Gesson, 2007, The Journal of organic chemistry.

Synthesis of rigid trichostatin A analogs as HDAC inhibitors.

C. Charrier, P. Bertrand, J. Roche, 2006, Bioorganic & medicinal chemistry letters.

Can we use the epigenetic bioactivity of caloric restriction and phytochemicals to promote healthy ageing

M. Lahtela-Kakkonen, E. Bártová, M. Vidaković, 2014 .

Physical and chemical assessment of 1,3 Propanediol as a potential substitute of propylene glycol in refill liquid for electronic cigarettes

L. Lemée, P. Bertrand, G. Frapper, 2018, Scientific Reports.

Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates.

J. Ovádi, P. Bertrand, M. Cuendet, 2016, Bioorganic & medicinal chemistry letters.

Synthesis of a selective HDAC6 inhibitor active in neuroblasts.

Giuseppe Marco Randazzo, C. Petit, P. Bertrand, 2016, Bioorganic & medicinal chemistry letters.

Persistent Silylated Phosphoranyl Radicals. Application to Dynamic Nuclear Polarization

P. Bertrand, S. Marque, M. Moussavi, 1997 .

Synthesis and Conformational Analysis of Macrocycles Related to 10-Oxa-epothilone

C. Bachmann, P. Bertrand, J. Gesson, 2004 .

Design and synthesis of tubulin ligands based on epothilones: a preliminary study

P. Renard, B. Pfeiffer, P. Bertrand, 2002 .

Chemistry for Oncotheranostic Gold Nanoparticles

T. Napporn, P. Bertrand, Fatima el Bahhaj, 2015 .

Dinuclear zinc(II) complexes of a Robson macrocycle

H. Adams, P. Bertrand, D. E. Fenton, 1995 .

Dinuclear silver(I) complexes of 24-membered bibracchial tetraimine Schiff base macrocycles derived from 2,5-diformylthiophene

H. Adams, P. Bertrand, D. E. Fenton, 1996 .

A new approach to the synthesis of substituted 4-imidazolidinones as potential antiviral and antitumor agents

P. Bertrand, A. Khodair, 1998 .

Synthesis of Macromonocyclic Hydroxamic Acids* (Review)

P. Bertrand, D. Borovika, P. Trapencieris, 2014, Chemistry of Heterocyclic Compounds.

Investigations into Competitive Cycloaddition/Cyclization or Elimination from 1,1-Dimethyl-propargylcarbamates of Anilines

P. Bertrand, V. Héroguez, F. Collette, 2011 .

Biological activities of substituted trichostatic acid derivatives

C. Charrier, P. Bertrand, J. Roche, 2009 .

The [2,3]-Wittig rearrangement route toward annonaceous acetogenins from furanoid glycals: a preliminary study

P. Bertrand, B. Renoux, J. Gesson, 1995 .

1H NMR analysis and conformation of bis-tetrahydrofurans related to annonaceous acetogenins

L. Autissier, P. Bertrand, B. Renoux, 1994 .

Approach to the synthesis of annonaceous acetogenins from D-glucose

P. Bertrand, J. Gesson, 1992 .

Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential

Judit Ovádi, Philippe Bertrand, J. Ovádi, 2017, Expert review of proteomics.

Easy and effective method to produce functionalized particles for cellular uptake

Philippe Bertrand, Marc Grégoire, P. Bertrand, 2013 .

Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery.

P. Bertrand, Fatima el Bahhaj, C. Blanquart, 2015, European journal of medicinal chemistry.

Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targeting.

P. Bertrand, Fatima el Bahhaj, C. Blanquart, 2014, Biomacromolecules.

Synthesis of small and medium size monocyclic hydroxamic acids (Review)*

P. Bertrand, P. Trapencieris, J. Strazdiņa, 2012, Chemistry of Heterocyclic Compounds.

Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy

P. Bertrand, Fatima el Bahhaj, C. Blanquart, 2016, Theranostics.

Interpreting clinical assays for histone deacetylase inhibitors.

P. Bertrand, N. Martinet, P. Bertrand, 2011, Cancer management and research.

Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

K. Nikolić, D. Agbaba, P. Bertrand, 2019, ACS medicinal chemistry letters.

The ROMP: A Powerful Approach to Synthesize Novel pH-Sensitive Nanoparticles for Tumor Therapy

P. Bertrand, C. Blanquart, V. Héroguez, 2019, Biomolecules.

Small molecules DNA methyltransferases inhibitors

Benoît Y. Michel, R. Benhida, P. Bertrand, 2012 .

Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma

M. Errami, P. Bertrand, C. Blanquart, 2018, Clinical Epigenetics.

Epigenetic metalloenzymes.

A. Mai, P. Cartron, P. Bertrand, 2018, Current medicinal chemistry.

Physical and chemical assessment of 1,3 Propanediol as a potential substitute of propylene glycol in refill liquid for electronic cigarettes

L. Lemée, P. Bertrand, G. Frapper, 2018, Scientific Reports.

Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds.

C. Charrier, P. Bertrand, C. Blanquart, 2011, Current cancer drug targets.

Inside PD-1/PD-L1,2 with their inhibitors.

P. Bertrand, Nicolas Boisgerault, 2023, European journal of medicinal chemistry.

Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression.

G. Estiu, O. Wiest, C. Charrier, 2009, Journal of medicinal chemistry.

Hammet Constants Effects in Microwave Cascade Etherification-Cyclization-Krapcho Reaction to Access [2,3]-Dihydrobenzofuran-3-ones from Salicylic Derivatives

P. Bertrand, Daniel Farran, 2012 .

Resolution of 2,3-dihydro-benzofuran-3-ols

C. Charrier, P. Bertrand, 2011 .

Cancer Management and Research Dovepress Interpreting Clinical Assays for Histone Deacetylase Inhibitors

P. Bertrand, N. Martinet, 2022 .

Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137)

P. Bertrand, M. Cuendet, C. Simões-Pires, 2017, Expert opinion on therapeutic patents.

Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targeting.

P. Bertrand, Fatima el Bahhaj, C. Blanquart, 2014, Biomacromolecules.

Inside HDAC with HDAC inhibitors.

P. Bertrand, 2010, European journal of medicinal chemistry.

Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues.

C. Charrier, P. Bertrand, J. Roche, 2007, Bioorganic & medicinal chemistry letters.

Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential

J. Ovádi, J. Olah, P. Bertrand, 2017, Espert Review of Proteomics.

Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective.

P. Bertrand, 2023, Journal of medicinal chemistry.